oxidopamine has been researched along with Pheochromocytoma, Extra-Adrenal in 10 studies
Oxidopamine: A neurotransmitter analogue that depletes noradrenergic stores in nerve endings and induces a reduction of dopamine levels in the brain. Its mechanism of action is related to the production of cytolytic free-radicals.
oxidopamine : A benzenetriol that is phenethylamine in which the hydrogens at positions 2, 4, and 5 on the phenyl ring are replaced by hydroxy groups. It occurs naturally in human urine, but is also produced as a metabolite of the drug DOPA (used for the treatment of Parkinson's disease).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (40.00) | 18.7374 |
| 1990's | 2 (20.00) | 18.2507 |
| 2000's | 1 (10.00) | 29.6817 |
| 2010's | 2 (20.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guo, L | 1 |
| Qu, B | 1 |
| Song, C | 1 |
| Zhu, S | 1 |
| Gong, N | 1 |
| Sun, J | 1 |
| Magalingam, KB | 1 |
| Radhakrishnan, A | 1 |
| Haleagrahara, N | 1 |
| Mei, JM | 1 |
| Niu, CS | 1 |
| Erlandsson, N | 1 |
| Baumann, B | 1 |
| Rössler, OG | 1 |
| Kaufmann, K | 1 |
| Giehl, KM | 1 |
| Wirth, T | 1 |
| Thiel, G | 1 |
| Snavely, MD | 1 |
| Motulsky, HJ | 1 |
| Moustafa, E | 1 |
| Mahan, LC | 1 |
| Insel, PA | 1 |
| Perez-Polo, JR | 1 |
| Tiffany-Castiglioni, E | 1 |
| Werrbach-Perez, K | 1 |
| Matthew, WD | 1 |
| Patterson, PH | 1 |
| Decker, DE | 1 |
| Althaus, JS | 1 |
| Buxser, SE | 1 |
| VonVoigtlander, PF | 1 |
| Ruppel, PL | 1 |
| Gassen, M | 1 |
| Pinchasi, B | 1 |
| Youdim, MB | 1 |
| Bing, GY | 1 |
| Notter, MF | 1 |
| Hansen, JT | 1 |
| Gash, DM | 1 |
10 other studies available for oxidopamine and Pheochromocytoma, Extra-Adrenal
| Article | Year |
|---|---|
Celastrol attenuates 6-hydroxydopamine-induced neurotoxicity by regulating the miR-146a/PI3K/Akt/mTOR signaling pathways in differentiated rat pheochromocytoma cells.
Topics: Adrenal Gland Neoplasms; Animals; Apoptosis; MicroRNAs; Neuroprotective Agents; Oxidopamine; Parkins | 2022 |
Rutin, a bioflavonoid antioxidant protects rat pheochromocytoma (PC-12) cells against 6-hydroxydopamine (6-OHDA)-induced neurotoxicity.
Topics: Animals; Antioxidants; Catalase; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; | 2013 |
Effects of CDNF on 6-OHDA-induced apoptosis in PC12 cells via modulation of Bcl-2/Bax and caspase-3 activation.
Topics: Adrenal Gland Neoplasms; Animals; Apoptosis; bcl-2-Associated X Protein; Caspase 3; Dopaminergic Neu | 2014 |
Lack of correlation between NF-kappaB activation and induction of programmed cell death in PC12 pheochromocytoma cells treated with 6-hydroxydopamine or the cannabinoid receptor 1-agonist CP55,940.
Topics: Adrenergic Agents; Animals; Apoptosis; Cyclic AMP; Cyclohexanols; DNA-Binding Proteins; I-kappa B Pr | 2002 |
beta-Adrenergic receptor subtypes in the rat renal cortex. Selective regulation of beta 1-adrenergic receptors by pheochromocytoma.
Topics: Adrenal Gland Neoplasms; Animals; Binding, Competitive; Epinephrine; Hydroxydopamines; Iodocyanopind | 1982 |
Model clonal system for study of neuronal cell injury.
Topics: Animals; Cell Line; Cell Survival; Central Nervous System; Clone Cells; Dose-Response Relationship, | 1983 |
The production of a monoclonal antibody that blocks the action of a neurite outgrowth-promoting factor.
Topics: Adrenal Gland Neoplasms; Animals; Antibodies, Monoclonal; Axons; Cell Line; Cyclophosphamide; Fluore | 1983 |
Competitive irreversible inhibition of dopamine uptake by 6-hydroxydopamine.
Topics: Adrenal Gland Neoplasms; Aminoisobutyric Acids; Animals; Binding, Competitive; Biological Transport; | 1993 |
Apomorphine is a potent radical scavenger and protects cultured pheochromocytoma cells from 6-OHDA and H2O2-induced cell death.
Topics: Adrenal Gland Neoplasms; Animals; Apomorphine; Cell Death; Free Radical Scavengers; Hydrogen Peroxid | 1998 |
Comparison of adrenal medullary, carotid body and PC12 cell grafts in 6-OHDA lesioned rats.
Topics: Adrenal Medulla; Animals; Carotid Body; Cell Line; Corpus Striatum; Cyclosporins; Graft Survival; Hy | 1988 |